IP Library Granted Patent US 10,729,895
Granted Patent B2
US 10,729,895 · App. 15/513,110 · Granted Aug 4, 2020

Active agent delivery devices and methods of using the same

Inventors: Kiana Aran (Berkeley, CA); Jacobo Paredes (Berkeley, CA); Niren Murthy (Berkeley, CA); Dorian Liepmann (Lafayette, CA); Kunwoo Lee (Albany, CA)
Assignee: The Regents of the University of California
A61M31/002A61K9/006A61K39/0005A61M31/00A61K2039/542A61M2202/064A61M2205/3324A61M2205/3334A61M2205/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,729,895
App. No.
15/513,110
Granted
Aug 4, 2020
Kind
B2
Abstract

Provided are active agent delivery devices configured to deliver an active agent formulation into or through a mucosal layer in a subject. The active agent delivery devices include a power reservoir configured to eject the active agent formulation at a pressure sufficient to deliver the active agent formulation into or through a mucosal layer in a subject. Methods of using the subject active agent delivery devices are also provided.

Claims (34)

1. An active agent delivery device comprising:

an active agent reservoir at an active agent reservoir end of the device configured to contain an active agent formulation;

a power reservoir at a power reservoir end of the device configured to eject the active agent formulation at a pressure sufficient to deliver the active agent formulation into or through a mucosal layer in a subject, wherein the power reservoir comprises one or more valves, wherein the one or more valves separates the power reservoir from the exterior of the device, wherein the one or more valves comprises a pH responsive material and is configured to degrade or dissolve and thereby provide an inlet into the power reservoir in response to a change in pH; and

a moveable separator separating the power reservoir from the active agent reservoir.

2. The active agent delivery device of claim 1 , wherein the pressure generated by the device is 30 kPa or more.

3. The active agent delivery device of claim 1 , wherein the active agent formulation is ejected from the device in 10 msec or less.

4. The active agent delivery device of claim 1 , wherein the active agent formulation is ejected from the device at a velocity of 1 m/s or more.

5. The active agent delivery device of claim 1 , wherein the device comprises a nozzle separating the active agent reservoir from the exterior of the device.

6. The active agent delivery device of claim 1 , wherein the power reservoir contains a gas generating material.

7. The active agent delivery device of claim 6 , wherein the gas generating material produces a gas upon contact with an aqueous medium.

8. The active agent delivery device of claim 7 , wherein the gas is a product of a chemical reaction.

9. The active agent delivery device of claim 6 , wherein the gas generating material is a volatile liquid.

10. The active agent delivery device of claim 9 , wherein the volatile liquid has a vaporization temperature ranging from 37.5° C. to 45° C.

11. The active agent delivery device of claim 1 , wherein the moveable separator contains a gas generating material.

12. The active agent delivery device of claim 9 , wherein the device comprises a heat reservoir in heat transfer relationship with the power reservoir, wherein the heat reservoir comprises a heat generating material that produces heat upon contact with an aqueous medium.

13. The active agent delivery device of claim 1 , wherein the pH responsive material comprises a polymer.

14. The active agent delivery device of claim 1 , wherein the device further comprises an aqueous medium reservoir configured to contact at least a portion of the power reservoir end of the device and activate the power reservoir.

15. The active agent delivery device of claim 14 , wherein the power reservoir contains a gas generating material and the aqueous medium reservoir contains an aqueous medium.

16. The active agent delivery device of claim 1 , wherein the active agent comprises a macromolecule.

17. The active agent delivery device of claim 16 , wherein the macromolecule comprises a protein.

18. The active agent delivery device of claim 1 , wherein the active agent formulation comprises a liquid.

19. The active agent delivery device of claim 1 , wherein the device comprises a tubular member having a planar surface at the active agent reservoir end and a hemispherical structure at the power reservoir end.

20. The active agent delivery device of claim 1 , wherein the device is configured to promote contact of the active agent reservoir end with a mucosal surface in a subject.

21. A method of delivering an active agent to a subject, wherein the method comprises administering an active agent delivery device of claim 1 to a subject.

22. The method of claim 21 , wherein the method is a method of treating the subject for a disease condition.

23. A kit comprising:

an active agent delivery device of claim 1 ; and

a packaging containing the active agent delivery device.

24. The kit of claim 23 , wherein the packaging contains two or more of the active agent delivery devices.

25. The kit of claim 23 , further comprising a mucosal treatment agent.

26. The active agent delivery device of claim 1 , wherein the one or more valves includes one or more holes and a pH responsive material.

27. The active agent delivery device of claim 1 , wherein the one or more valves comprises a hole in the wall of the power reservoir.

28. The active agent delivery device of claim 1 , wherein the one or more valves degrade or dissolve at a pH of 4 or less.

29. The active agent delivery device of claim 1 , wherein the one or more valves degrade or dissolve at a pH of 5 or more.

Assignments (4)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
SECURITY INTEREST Recorded Dec 21, 2023
From: BIORA THERAPEUTICS, INC.
To: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
Reel/Frame 066089/0235 →
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042782/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2017
From: ARAN, KIANA; PAREDES, JACOBO; MURTHY, NIREN; LIEPMANN, DORIAN; LEE, KUNWOO
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 042549/0557 →
Continuity (2)
Provisional Application 62057887 · Sep 30, 2014
Related Publication 20170246438A1 · Aug 31, 2017